Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | Over 300 researchers from around the world joined us in San Francisco for our Early Detection of Cancer Research Conference last month.
Our keynote speaker, Peter Sasieni, opened the event with a provocative talk on the need for new trial methods for evaluation of cancer screening technologies and the adoption of alternative study endpoints to enable more efficient trials.
We also heard exciting talks on the biology of early and pre-cancers, emerging technologies, insights from clinical trials and the potential for artificial intelligence to drive progress in early detection.
Through a series of flash talks, we heard from researcher-patient representative duos on the importance of patient and public involvement in early detection research.
The conference featured lively discussions on the journey of translating scientific innovations from the lab to commercialisation, how we can evaluate the cancer screening technologies of the future, and much more.
We are already looking forward to the 2025 edition taking place on 21-23 October in Portland, Oregon.
Register your interest today
Kind regards,
David Crosby
Head of Prevention and Early Detection Research
Cancer Research UK |
|
| | |
|
|
|
|
Upcoming funding deadlines |
|
| | |
|
|
Antonis Antoniou wins Don Listwin Award |
| | | Congratulations to Professor Antonis Antoniou for winning the Don Listwin Award in recognition of his contributions to the field of early cancer detection.
In our recent Early Detection of Cancer Conference, we proudly recognised Antonis’ and his team’s work on understanding cancer risks for genetically susceptible individuals, statistical techniques for modelling cancer susceptibility and the development of risk prediction tools for clinical use.
"I’m deeply honoured that our team’s work, particularly on breast and ovarian cancer risk prediction models and tools, is being recognised with this award. These advancements empower informed decisions on cancer screening and prevention," said Antonis from the University of Cambridge. |
| | |
|
|
|
| | | | | Are you interested in the biological mechanisms underlying both ageing and cancer development, and the translation of research into cancer primary prevention approaches?
Our co-chairs Walid Khaled (University of Cambridge) and Lynne Cox (University of Oxford) will lead the discussions about future directions for the field during a full day workshop.
Join us on 28 January at the Royal Society of Chemistry and contribute to generating new perspectives and collaborations for research projects. | | |
| | | | | | | Cathie Sudlow, chair of our Early Detection and Diagnosis Research Committee, has published an independent review of the UK health data landscape.
Titled “Uniting the UK’s Health Data: A Huge Opportunity for Society”, the review highlights health data as critical infrastructure, essential for equitable and effective healthcare delivery and enabling research across the UK.
The report calls for unifying the fragmented health data systems, fostering data sharing through federated networks, and linking health data with other societal datasets, such as those on housing and pollution.
The review also emphasises the need to enhance public trust and recommends creating a national health data service. | | |
|
|---|
|
|
|
|
Developing target product profiles to support better cancer tests |
| Our Early Detection and Diagnosis of Cancer Roadmap highlighted how target product profiles (TPPs) can help researchers, innovators and companies overcome barriers to developing new diagnostic tests.
Now, a team led by Bethany Shinkins (University of Warwick) and Jacqueline Dinnes (University of Birmingham) is creating practical resources to develop TPPs that can be used to bring new cancer diagnostics to the screening and primary care settings.
This work also follows a report by our strategic evidence team, commissioned from RAND Europe and the Office of Health Economics exploring how target product profiles can support robust innovation in earlier cancer diagnosis. |
| | |
|
|
|
User-first breast cancer detection |
| | | Dotplot is a start-up focused on breast cancer early detection, and the winner of the New Start-up of the Year Award at this year's Cancer Research Horizons Innovation and Entrepreneurship Awards. Cancer Research Horizons is the innovation arm of Cancer Research UK.
To help detect breast cancer earlier, Dotplot is developing an at-home self-check tool to enable users to track changes in breast tissue and flag any abnormalities that require a visit to the GP.
As product designers, Dotplot’s founders Shefali Bohra and Debra Babalola put users at the centre of their creative process, cycling through concepts and ideas to find what resonates with people.
Read more to find out how they turned a master’s project into an award-winning start-up in a little over a year. |
| | |
|
|
|
Get your ticket for our Cancer Prevention Research Conference |
| Join us for our next Cancer Prevention Research Conference taking place on 25-27 June in London.
In its second edition, the event is hosted by us in collaboration with the American Cancer Society and the National Cancer Institute.
Hear from our keynote speakers Charles Swanton (The Francis Crick Institute), Elisabete Weiderpass (International Agency for Research on Cancer), Allan Balmain (University of California San Francisco) and much more.
Stay up to date with our programme on our website and by following #PrevConf25 on social media. |
| | |
|
|
|
| | | | | Postdocs provide much of the fabric that underpins research integrity, says Andrew Porter, Research Integrity and Training Adviser at the Cancer Research UK Manchester Institute.
In our latest research integrity column, Andrew recognises the role that postdocs play in supporting research integrity.
From bringing new research practice to the lab and championing open research principles to training peers and fostering transparent conversations, postdocs play an essential role in building a health research culture. | | |
| | | | | | | Do you want to learn more about the new cancer data product offered by the National Disease Registration Service?
Join an online workshop on 3 December between 09:30-12:30 to understand how this product enables users to build a bespoke dataset more tailored to their research question.
The aim of this session is to raise awareness across the cancer research community and to generate feedback with a view to help shape its future development from data users’ perspectives. | | |
|
|---|
|
|
|
|
Been forwarded this email? Subscribe to our newsletter to stay up to date. |
| | |
|
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
